International Journal of Radiation Oncology * Biology * Physics
Volume 81, Issue 2 , Pages 418-423 , 1 October 2011

Three or Four Fractions of 4–5 Gy per Week in Postoperative High-Dose-Rate Brachytherapy for Endometrial Carcinoma

  • Angeles Rovirosa, M.D., Ph.D.

      Affiliations

    • Radiation Oncology Department, Hospital Clinic, Institut d'Investicació Biomédica Agustí Pi i Sunyer, Barcelona, Spain
    • Corresponding Author InformationReprint requests to: Angeles Rovirosa, M.D., Ph.D., Radiation Oncology Department, Hospital Clínic, University of Barcelona, C/ Villarroel 170, 08036, Barcelona, Spain. Tel and Fax: (+34) 932275542
    • ,
  • Carlos Ascaso, Ph.D.

      Affiliations

    • Public Health Department, University of Barcelona, IDIBAPS, Spain
    • ,
  • Alberto Sánchez-Reyes, Ph.D.

      Affiliations

    • Radiation Oncology Department, Hospital Plató, Barcelona, Spain
    • ,
  • Antonio Herreros

      Affiliations

    • Radiation Oncology Department, Hospital Clinic, Institut d'Investicació Biomédica Agustí Pi i Sunyer, Barcelona, Spain
    • ,
  • Rosa Abellana, M.D., Ph.D.

      Affiliations

    • Public Health Department, University of Barcelona, IDIBAPS, Spain
    • ,
  • Jaume Pahisa, M.D., Ph.D.

      Affiliations

    • Gynecology and Obstetrics Department, Hospital Clinic, Barcelona, Spain
    • ,
  • Jose Antonio Lejarcegui, M.D., Ph.D.

      Affiliations

    • Gynecology and Obstetrics Department, Hospital Clinic, Barcelona, Spain
    • ,
  • Albert Biete, M.D., Ph.D.

      Affiliations

    • Radiation Oncology Department, Hospital Clinic, Institut d'Investicació Biomédica Agustí Pi i Sunyer, Barcelona, Spain

Received 11 January 2010 ,Revised 16 March 2010 ,Accepted 7 June 2010.

References 

  1. O'Connell D, Howard N, Joslin CA, et al. A new remotely controlled unit for the treatment of uterine carcinoma. Lancet. 1965;2:570–571
  2. Joslin CA, Vaishmpayan GV, Mallik A. The treatment of the early cancer of the corpus uteri. Br J Radiol. 1977;50:35–45
  3. Orthon CG. High-dose-rate brachytherapy may be radiobiologically superior to low-dose rate due to slow repair of late-responding normal tissue cells. Int J Radiat Oncol Biol Phys. 2001;49:183–189
  4. Nag S, Erickson B, Parikh S, et al. The American Brachytherapy Society recommendations for high-dose-rate brachytherapy for carcinoma of the endometrium. Int J Radiat Oncol Biol Phys. 2000;48:779–790
  5. Alektiar KM, Venkatram E, Chi DS, et al. Intravaginal brachytherapy alone for intermediate-risk endometrial cancer. Int J Radiat Oncol Biol Phys. 2005;62:111–117
  6. TMN Classification of Malignant Tumours. Union Internationale Contre le Cancer, Sobin LH, Wittekind, editors. Washington, DC: Wiley-Liss; 2002. p. 160–164.
  7. Keys HM, Roberts JA, Brunetto VL, et al. A Phase III trial of surgery with or without adjunctive external pelvic radiation therapy in intermediate risk endometrial carcinoma: A Gynecologic Oncology Group study. Gynecol Oncol. 2004;92::774–751
  8. Report 38: Dose and volume specification for reporting intracavitary therapy in gynecology. International Commission on Radiation Units and measurements Bethesda, MD: International Commission on Radiation Units and Measurements; 1985.
  9. Late effects consensus conference. RTOG/EORTC. Radiother Oncol. 1995;35:5–7
  10. Feldmann U, Schneider B, Klinkers H, Haeckel R. A multivariate approach for the biometric comparison of analytical methods in clinical chemistry. J Clin Chem Clin Biochem. 1981;19:121–137
  11. Lin LI. A concordance correlation coefficient to evaluate reproducibility. Biometrics. 1989;45:255–268
  12. Nag S, Gupta N. A simple method of obtaining equivalent doses for use in HDR brachytherapy. Int J Radiat Oncol Biol Phys. 2000;46:507–513
  13. Sood B, Garg M, Avadhani J, et al. Predictive value of linear-quadratic model in the treatment of cervical cancer using high-dose-rate brachytherapy. Int J Radiat Oncol Biol Phys. 2002;54:1377–1387
  14. Pearcey RG, Petereit DG. Postoperative high dose rate brachytherapy in patients with low to intermediate risk endometrial cancer. Radiother Oncol. 2000;1:17–22
  15. Elliot P, Green D, Coates A, et al. The efficacy of postoperative vaginal radiation in preventing vaginal recurrence in endometrial cancer. Int Gynecol Cancer. 1994;4:84–93
  16. Onsrud M, Strickert T, Marthinsen ABL. Late reactions after postoperative high-dose-rate intravaginal brachytherapy for endometrial cancer: A comparison of standardized and individualized target volumes. Int J Radiat Oncol Biol Phys. 2001;49:749–755
  17. Creutzberg CL, van Putten WL, Koper PC, et al. The morbidity of treatment for patients with Stage I endometrial cancer: Results from a randomized trial. Int J Radiat Oncol Biol Phys. 2001;51:1246–1255
  18. Greven KM, Corn BW. Endometrial cancer [review]. Curr Probl Cancer. 1997;21:65–127
  19. Potter R, Gerbaulet A, Haie-meder C. Endometrial cancer. In:  Gerbaulet A,  Potter R,  Mazeron JJ, et al. editor. The GEC ESTRO handbook of brachytherapy. Leuven, Belgium: ACCO; 2002;p. 301–364
  20. Sorbe BG, Smeds ACH. Postoperative vaginal irradiation with high dose rate afterloading technique in endometrial carcinoma Stage I. Int J Radiat Oncol Biol Phys. 1990;19:305–314
  21. Himmelman A, Notter G, Turesson I. Normal tissue reactions to high dose-rate intracavitary irradiation of the vagina with different schedules and dose levels. Strahlentherapie. 1985;161:163–167
  22. Kucera H, Vavra N, Weghaupt K. Benefit of external irradiation in Stage I endometrial carcinoma: A prospective clinical trial of 605 patient who received postoperative vaginal irradiation and additional pelvic irradiation in the presence of unfavourable prognostic factors. Gynecol Oncol. 1990;38:99–104
  23. Creutzberg CL. GOG-99: Ending the controversy regarding pelvic radiotherapy for endometrial carcinoma. Gynecol Oncol. 2004;92:704–743
  24. Lin LL, Mutch DG, Rader JS, et al. Gynecol Oncol. 2007;106:215–220
  25. Martinez-Monge R, Nagore G, Cambeiro M, et al. Intravaginal 1-week high-dose-rate brachytherapy alone for Stages I–II endometrial cancer. Brachytherapy. 2007;6:195–200
  26. Weiss E, Hirnle P, Arnold-Bofinguer H, et al. Adjuvant vaginal high-dose-rate afterloading alone in endometrial carcinoma: Patterns of relapse and side effects following low-dose therapy. Gynecol Oncol. 1998;71:72–76
  27. Anderson JM, Stea B, Hallum AV, et al. High-dose-rate posoperative vaginal cuff irradiation alone for Stage IB and IC endometrial cancer. Int J Radiat Oncol Biol Phys. 2000;46:417–425
  28. Röper B, Astner ST, Heydemann-Obradovic A, et al. Ten-year data on 138 patients with endometrial carcinoma and postoperative vaginal brachytherapy alone: No need for external-beam radiotherapy in low and intermediate risk. Gynecol Oncol. 2007;107:541–548
  29. Pellizon ACA, Fogarolli RC, Miziara M, et al. Morbidity of adjuvant high-dose-rate brachytherapy for low to intermediate risk endometrial carcinoma completely resected. Int J Cancer. 1996;(Suppl 96):105–108
  30. Sorbe B, Straumits A, Karlsson L. Intravaginal high-dose-rate brachytherapy for Stage I endometrial cancer: A randomized study of two dose per fractions levels. Int J Radiat Oncol Biol Phys. 2005;62:1385–1389

 Conflict of interest: none.

PII: S0360-3016(10)00783-2

doi: 10.1016/j.ijrobp.2010.06.001

International Journal of Radiation Oncology * Biology * Physics
Volume 81, Issue 2 , Pages 418-423 , 1 October 2011

Article Tools